实用中医药杂志2024,Vol.40Issue(7) :1299-1301.

参附强心丸辅治慢性心力衰竭临床观察

熊珊 赵英丽 韩硕
实用中医药杂志2024,Vol.40Issue(7) :1299-1301.

参附强心丸辅治慢性心力衰竭临床观察

熊珊 1赵英丽 1韩硕2
扫码查看

作者信息

  • 1. 南阳医学高等专科学校第一附属医院全科医学科,河南 南阳 473000
  • 2. 河南省南阳市中心医院产科,河南 南阳 473005
  • 折叠

摘要

目的:观察参附强心丸辅治慢性心力衰竭的疗效.方法:92例分为两组,对照组45例用西药治疗,观察组47例用参附强心丸及西药治疗.结果:总有效率观察组比对照组高(P<0.05).两组治疗后中医证候积分均下降,且观察组比对照组低(P<0.05).治疗后两组ET-1及炎性因子hs-CRP、TNF-α均降低,且观察组比对照组低(P<0.05).两组不良反应发生率比较差异无统计学意义(P>0.05).结论:参附强心丸辅治慢性心力衰竭疗效较好,且安全.

Abstract

Objective:To observe the curative effect of Shenfu Qiangxin Pills in adjuvant treatment of chronic heart failure.Methods:Ninety-two cases were divided into two groups.Forty-five cases in the control group were treated with western medicine while forty-seven cases in the observation group were treated with Shenfu Qiangxin Pills and western medicine.Results:The total effective rate of the observation group was higher than that of the control group(P<0.05).After treatment,the scores of TCM syndromes in both groups decreased,and those in the observation group were lower than the control group(P<0.05).After treatment,ET-1 and inflammatory factors hs-CRP and TNF-α in the two groups decreased,and those in the observation group were lower than the control group(P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion:Shenfu Qiangxin Pills is effective and safe in the treatment of chronic heart failure.

关键词

慢性心力衰竭/参附强心丸/对照治疗观察

Key words

Chronic heart failure/Shenfu Qiangxin Pills/Control treatment and observation

引用本文复制引用

出版年

2024
实用中医药杂志
重庆医科大学中医药学院

实用中医药杂志

影响因子:0.546
ISSN:1004-2814
段落导航相关论文